Glyn Edwards steps in at BIA as Nigel Gaymond leaves
This article was originally published in Scrip
The UK's trade association for bioscience, the BioIndustry Association (BIA), has appointed Glyn Edwards interim chief executive effective immediately. He will be replacing Nigel Gaymond, who has left the organisation to pursue other opportunities. Mr Edwards most recently served as CEO of Antisoma from 1998-2011, and has previously served on BIA's board.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.